Osteoarthritis relief - Price offer wins UCB arthritis drug UK green light - Reuters
|
Price offer wins UCB arthritis drug UK green light
Reuters BR) rheumatoid arthritis drug Cimzia, after the Belgian drugmaker agreed to provide it for free during the first 12 weeks. The National Institute for Health … Patients to get potent new arthritis drug 'after makers agree free three-month … NICE blesses Cimzia after UCB price cut UCB Gives Cimzia Away to Get UK Rheumatoid Arthritis Coverage |
|
MorphoSys Enrolls First Patient in Phase 1b/2a Clinical Trial for MOR103 …
CNNMoney.com (press release) "We are very pleased that our Phase 1b/2a study in patients with rheumatoid arthritis has now started according to plan," commented Dr. Arndt Schottelius, … MorphoSys announces enrolment of first patient in Phase 1b/2a clinical trial … |